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Abstract
Background: Human T-cell leukemia virus type I (HTLV-1) can cause an aggressive malignancy known as adult T-cell
leukemia/lymphoma (ATL) as well as inflammatory diseases such as HTLV-1-associated myelopathy/tropical spastic
paraparesis (HAM/TSP). A transgenic mouse that expresses HTLV-1 Tax also develops T-cell leukemia/lymphoma and an
inflammatory arthropathy that resembles rheumatoid arthritis. The aim of this study was to identify the primary T-cell
subsets involved in the development of arthropathy in Tax transgenic mice.
Principal Findings: By 24 months of age, Tax transgenic mice developed severe arthropathy with a cumulative incidence of
22.8%. The pathological findings of arthropathy in Tax transgenic mice were similar to those seen in human rheumatoid
arthritis or mouse models of rheumatoid arthritis, with synovial proliferation and a positive rheumatoid factor. Before the
onset of spontaneous arthropathy, young and old Tax transgenic mice were not sensitive to collagen and did not develop
arthritis after immunization with type II collagen. The arthropathic Tax transgenic mice showed a significantly decreased
proportion of splenic CD4
+ T cells, whereas the proportion of splenic CD8
+ T cells was increased. Regulatory T cells
(CD4
+CD25
+Foxp3
+) were significantly decreased and CD8
+ T cells that expressed the chemokine receptor CCR4
(CD8
+CCR4
+) were significantly increased in arthropathic Tax transgenic mice. The expression of tax mRNA was strong in the
spleen and joints of arthropathic mice, with a 40-fold increase compared with healthy transgenic mice.
Conclusions: Our findings reveal that Tax transgenic mice develop rheumatoid-like arthritis with proliferating synovial cells
in the joints; however, the proportion of different splenic T-cell subsets in these mice was completely different from other
commonly used animal models of rheumatoid arthritis. The crucial T-cell subsets in arthropathic Tax transgenic mice appear
to resemble those in HAM/TSP patients rather than those in rheumatoid arthritis patients.
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Introduction
Human T-cell leukemia virus type I (HTLV-1) was the first
human retrovirus to be isolated. Infection with HTLV-1 can
result in an aggressive malignancy known as adult T-cell
leukemia/lymphoma (ATL) or in inflammatory diseases, such
as HTLV-1-associated myelopathy/tropical spastic paraparesis
(HAM/TSP), after a prolonged period of latency often lasting
between 20 and 50 years [1]. The lifetime incidence of ATL
among carriers of HTLV-1 is estimated to be 1 to 5%, whereas
that of HAM/TSP is 0.3 to 4% [2]. The lifetime incidence of
HTLV-1-associated diseases in general, including ATL, HAM/
TSP, and other inflammatory diseases such as uveitis, polymyo-
sitis, and arthropathy, may be close to 10% [2]. Why HTLV-1-
infected individuals develop different types of diseases and the
mechanisms through which HTLV-1 causes these diseases
remain unclear.
The tax gene product encoded by the pX region of the HTLV-1
genome appears to be a key element in the development of
HTLV-1-associated diseases [1–4]. Tax enhances productive virus
replication by driving viral gene transcription through the cAMP-
responsive element located in the long terminal repeat of the viral
genome [3,4]. Tax also activates the expression of many cellular
genes, including those for cytokines, cytokine receptors, and
immediate early transcription factors via cellular signal transduc-
tion pathways, such as those mediated by the transcription factor
nuclear factor-kappaB (NF-kB) and serum response factor [3,4].
One of the best ways to investigate the role of Tax in
pathogenesis in vivo is to create a transgenic mouse model that
expresses Tax and to study the model before and after disease
develops. Accordingly, transgenic mouse models carrying tax have
been shown to develop mesenchymal tumors, neurofibromas,
arthropathy, and large granular lymphocytic leukemia; however,
none of these transgenic mice develops a T-cell leukemia/
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created in which tax expression was restricted to thymocytes by
using the proximal promoter of the lymphocyte-specific protein
tyrosine kinase (Lck) gene. These mice developed pre-T-cell
(CD4
–CD8
–) leukemia/lymphoma [6]. Furthermore, our group
created a transgenic mouse model of HTLV-I by using the distal
promoter of Lck to express tax in mature thymocytes and
peripheral T lymphocytes. Our transgenic mice developed a
mature T-cell leukemia/lymphoma (CD4
+ or CD8
+) similar to
ATL [7]. Our results suggest that HTLV-1 Tax promotes
oncogenesis not only in immature T cells but also in mature T
cells.
While expanding our Lck-distal-tax transgenic mouse colony, we
found that inflammatory arthropathy developed among the Tax-
positive mice without leukemia but not among their Tax-negative
littermates. The inflammatory disease developed after a prolonged
latency period, like that seen among humans infected with HTLV-
1. Inflammatory arthropathy has been reported for other Tax
transgenic mouse models [8,9]; however, leukemia does not also
occur in these other models. Our Tax transgenic mouse model is
the first to model both neoplastic and inflammatory disease,
similar to HTLV-1 infection in humans.
Recent advances using conventional animal models of rheuma-
toid arthritis have led to a better understanding of the role of
different immune cells in the pathogenesis of disease. Treatment
with an antibody against CD4 suppresses the onset of rheumatoid
arthritis, suggesting a role for CD4 T cells in disease progression
[10]. CD4 T cells are classified into Th1, Th2, and Th17 subsets
according to the type of cytokine produced [11]. Th1 cells, which
also produce interferon-c (IFN-c), have traditionally been
considered to be the major player in collagen-induced arthritis
[12]; however, recent data suggest a central role for IL-17-
producing Th17 cells in the pathogenesis observed in the collagen-
induced arthritis model [13,14]. In addition, CD4
+CD25
+Foxp3
+
regulatory T (Treg) cells appear to have suppressive or regulatory
activity and play a crucial role in maintaining self-tolerance [15].
The transfer of exogenous CD4
+CD25
+ T cells or Foxp3
+-
transduced CD4
+ cells from healthy mice into pre-arthritic mice
inhibits the development of arthritis, suggesting a regulatory role
for Treg cells in the development of arthritis [16–18].
Little is known about the immune cell subsets that play
important roles in the pathogenesis of arthritis induced by HTLV-
1 Tax. Furthermore, it is unclear whether the inflammatory
disease that develops in Tax transgenic mice is similar to that
which develops in humans infected with HTLV-1. To address
these issues, we identified the crucial lymphocyte subsets required
for the development of arthropathy in Tax transgenic mice.
Results
Incidence of disease in Tax transgenic mice
We previously reported on the development of mature T-cell
leukemia/lymphoma in Tax transgenic mice [7]. In the present
study, we determined the 2-year cumulative incidence of other
diseases in 114 Tax transgenic mice and 105 non-transgenic mice
(Figure 1A), and we used real-time RT-PCR to quantify tax
mRNA expression in samples from organ lesions of Tax transgenic
mice and in splenocytes from transgenic mice free of disease
(Figure 1B). The incidence of mature T-cell leukemia/lymphoma
was 28.1% in Tax transgenic mice, whereas the incidence was only
1% in non-transgenic mice (Figure 1A). The leukemic cells in the
spleens of leukemic mice exhibited a modest increase (0.3- to 8-
fold) in tax mRNA expression compared with splenocytes from
disease-free transgenic mice (Figure 1B). Severe arthropathy was
absent in non-transgenic mice, but the incidence among Tax
transgenic mice was 22.8% (Figure 1A). The joints of arthropathic
Tax transgenic mice showed a 14.1- to 72.5-fold increase in tax
mRNA expression compared with expression in the spleens of
healthy transgenic mice (Figure 1B). None of the Tax transgenic
mice developed both leukemia and arthropathy.
Three Tax transgenic mice developed HAM/TSP-like disease
with symmetrical paraparesis of the hind legs (Figure 1A);
however, the disease was not inflammatory, but involved a
proliferation of lymphoid tumor cells in the spinal cord (data not
shown). A few Tax transgenic and non-transgenic mice showed
intense dermatitis, but tax mRNA expression was absent in the
lesions of diseased Tax transgenic mice (Figure 1A, B). Other
tumors observed in both groups of mice included B cell
lymphoma, hepatocarcinoma, and ovarian cancer, but tax mRNA
was not expressed in these tumors (Figure 1A, B).
We reported previously that the cumulative incidence of T-cell
leukemia/lymphoma increases over time [7]. In our present study,
we found that the cumulative incidence of arthropathy in Tax
transgenic mice also increased over time (Figure 1C, left). Similar
to the findings for T-cell leukemia/lymphoma, arthropathy
occurred after a prolonged latency period of at least 9 months
(Figure 1C, left). The arthropathic Tax transgenic mice showed
erythema and swelling of the foot pads and marked swelling of the
ankles and digits, but they did not show intense gait disturbance.
There was no statistically significant gender difference in the 2-
year cumulative incidence of arthropathy; however, there was an
apparent trend that male mice had a somewhat higher cumulative
incidence than female mice (Figure 1C, right; P=0.082, one-tailed
Fisher’s exact test).
Clinical signs of arthropathy in Tax transgenic mice
The progression of arthropathy in Tax transgenic mice initially
involved the hind limbs (Figure 2A, lower panel), whereas these
symptoms were absent in healthy non-transgenic littermates
(Figure 2A, upper panel). The radiographic images of the hind
legs in arthropathic Tax transgenic mice showed that the ankle
joints were eroded and deformed, and they exhibited ankylosis
(Figure 2B); the clinical arthritis score was 0 (left) for a healthy
transgenic mouse, and 2 (middle) or 3 (right) for an arthropathic
Tax transgenic mouse. Furthermore, calcification of ligaments and
spur formation were also observed in arthropathic Tax transgenic
mice. In age-matched mice without Tax expression, the joints
were always normal.
Whole-body radiographic images of arthropathic Tax trans-
genic mice showed mainly bone destruction of the tarsal joints
bilaterally (Figure 2C, D). In some instances, bone destruction was
also observed in the carpal joints (Figure 2E), and in rare instances
bone destruction was observed in the knees (data not shown).
Hypercalcemia is frequently observed in ATL patients [19].
Serum calcium levels in arthropathic transgenic mice were
significantly higher compared with age-matched healthy trans-
genic and non-transgenic mice (Figure 2F).
NF-kB is a transcription factor, and its activation is increased in
the synovium of patients with rheumatoid arthritis [20] and is
thought to be implicated in the cartilage destruction that
accompanies rheumatoid arthritis [21]. We measured the DNA-
binding activity of NF-kB in the joints of arthropathic Tax
transgenic mice using an ELISA. The inflammatory cells in the
joints of arthropathic Tax transgenic mice had significantly higher
levels of NF-kB compared with cells in the joints of healthy
transgenic mice (Figure 2G). There was no difference in NF-kB
activation between healthy transgenic mice and healthy non-
transgenic mice from the same litter.
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transgenic (non-Tg) mice. (A) Major phenotypes of disease were mature T-cell leukemia/lymphoma and arthropathy. The mice developed mature T-
cell leukemia/lymphoma with an incidence of 28.1% and severe arthropathy with an incidence of 22.8%. (B) Expression of tax mRNA in lesions of
arthropathic Tax transgenic mice relative to that in the spleens of healthy transgenic mice (n=5 per group). Higher levels of tax mRNA were found in
the joints of arthropathic Tax transgenic mice compared with leukemic Tax transgenic mice (n=5 per group). (C) Arthropathy develops in Tax
transgenic mice after a prolonged latency period of at least 9 months (left panel). The distribution of the cumulative incidence of arthropathy
according to gender: male mice have an apparent higher tendency to develop arthropathy than female mice, although the difference was not
statistically significant (right panel; P=0.082, one-tailed Fisher’s exact test).
doi:10.1371/journal.pone.0018518.g001
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PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18518Figure 2. Arthropathy in Tax transgenic mice. (A) Hind legs of control non-transgenic mice (upper panel). Marked swelling of the ankles and
digits of arthropathic Tax transgenic mice (lower panel). (B) Representative radiographic images of the hind legs of arthropathic Tax transgenic mice
(Arthropathy) showed that the ankle joints were eroded, deformed, exhibited ankylosis, and clinically scored 2 (middle image) and 3 (right image).
There was no lesion, however, in clinically healthy transgenic mice (Normal; left image). (C) Radiographic images of the whole body of a clinically
healthy (left panel) mouse and an arthropathic (right panel) transgenic mouse. Bone destruction was observed mainly in the tarsal joint bilaterally
(arrowheads). (D) Magnification of the radiographic images (46) of the right hind legs in arthropathic (upper panel) and healthy (lower panel)
transgenic mice. Bone destruction was restricted to the tarsal joint in arthropathic mice (arrow). (E) Bone destruction was observed in the tarsal joint
bilaterally in all cases of arthropathic Tax transgenic mice. In some arthropathic Tax transgenic mice, bone destruction was also observed in the carpal
joint bilaterally (16.6%, n=24). (F) Serum calcium levels of arthropathic Tax transgenic mice (Arthropathy; n=8) and age-matched healthy transgenic
mice (Normal; n=8) and non-transgenic control mice (non-Tg; n=8). The serum calcium levels in arthropathic Tax transgenic mice were significantly
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mice
Arthropathic Tax transgenic mice developed splenomegaly and
lymphadenopathy; however, the arthropathic Tax transgenic mice
showed no evidence of atypical lymphocytes, such as leukemic cells,
in the spleen or lymph nodes (data not shown). The main
histological finding of rheumatoid arthritis in humans is an inflamed
synovium [22]. Marked proliferation of the synovial tissues was
observed in arthropathic Tax transgenic mice, as shown in
Figures 3A and B. The ankle joints of arthropathic Tax transgenic
mice showed papillary proliferation of synovial cells (Figure 3A,
arrows) and irregular surface of the joint. Synovial proliferation and
intense infiltration with inflammatory cells was observed in the
joints of arthropathic Tax transgenic mice. Furthermore, synovial
pannus-like granulation tissues invaded bone and cartilage in
arthropathic Tax transgenic mice (Figure 3C). The knee joints
rarely showed severe destruction of the articular surface or fibrous
adhesion of bones, similar to the fibrous ankylosis seen in
rheumatoid arthritis patients (Figure 3D; arrows).
Augmentation of proinflammatory cytokine and autoantibody
production in arthropathic Tax transgenic mice.
We measured serum levels of rheumatoid factor and antibodies
against single-stranded DNA (ssDNA) for evidence of autoimmu-
nity. Both anti-ssDNA and rheumatoid factor were elevated
significantly in arthropathic Tax transgenic mice compared with
age-matched healthy Tax transgenic and non-transgenic mice
(Figure 4A, B). We next used semi-quantitative RT-PCR to
investigate cytokine gene expression in the joints of arthropathic
Tax transgenic mice (Figure 4C). Expression of mRNAs encoding
the proinflammatory cytokines interleukin-1b (IL-1b), interleukin-
6 (IL-6), and macrophage migration inhibitory factor (MIF) was
detected in the joints of arthropathic Tax transgenic mice but not
in the joints of healthy transgenic mice from the same litter.
Tumor necrosis factor-a (TNF-a) expression was not detected in
the joints of either arthropathic or healthy transgenic mice.
We next used ELISA to measure serum levels of the
proinflammatory cytokines IL-6, TNF-a, and interleukin-17A
(IL-17A) in arthropathic mice. Serum IL-6 concentrations in
arthropathic Tax transgenic mice were significantly higher than
those in healthy transgenic mice or non-transgenic mice
(Figure 4D). Serum levels of TNF-a and IL-17A were below the
detection limits of the ELISAs we used (Figure 4E, F).
Induction of arthritis in Tax transgenic mice with type II
collagen
Type II collagen can induce arthritis in rats and mice [23]. The
major histocompatibility complex loci have been found to be
important in influencing the susceptibility of mice to type II
collagen. Mice with the DBA/1 (H-2
q) or B10.RIII (H-2
r)
haplotype, and their congenic strains, are susceptible to colla-
gen-induced arthritis [24–26]. Mice without the H-2
q or H-2
r
haplotypes rarely develop collagen-induced arthritis. Some studies,
however, have reported that pX transgenic mice (H-2
k) injected
with type II collagen develop collagen-induced arthritis [27,28].
Therefore, we examined the susceptibility of Tax transgenic mice
of the strain DBA/2 (H-2
d)6C57BL/6 (H-2
b) to type II collagen–
Figure 3. Histological findings of arthropathy in Tax transgenic mice. (A) An ankle joint showed papillary proliferation of synovial cells
(arrowheads) and irregular surface of the joint (bar, 500 mm). (B) A high-power view showed lymphocyte infiltration and capillary proliferation at the
area of synovial proliferation in panel A (bar, 100 mm). (C) Synovial proliferation and infiltrating inflammatory cells caused disappearance of cartilage
of the articular surface and erosion of the bone similarly to pannus (bar, 100 mm). (D) A knee joint rarely showed severe destruction of the articular
surface or fibrous adhesion of bones, indicated by black arrows, similarly to fibrous ankylosis (bar, 1000 mm).
doi:10.1371/journal.pone.0018518.g003
increased compared with non-transgenic mice. ** P,0.01. (G) NF-kB activation in lesions of diseases in transgenic mice. Inflammatory cells from the
joints of arthropathic Tax transgenic mice showed constitutive activation of NF-kB, which was significantly elevated compared with normal cells
derived from healthy transgenic and non-transgenic control mice (n=5 per group). * P,0.05.
doi:10.1371/journal.pone.0018518.g002
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10 transgenic mice developed arthritis (Figure 5A). Because of the
long latency period until the development of arthropathy in our
Tax transgenic mice, we also examined the susceptibility of old
Tax transgenic mice to type II collagen–induced arthritis. One of
10 old Tax transgenic mice (10%) developed weak arthropathy
(total arthritis score 2) before inoculation with type II collagen;
however, the arthropathy observed in that mouse did not become
more severe after inoculation with type II collagen, and none of
the other mice developed arthropathy (Figure 5B).
Percentages of CD4
+ T cells and CD8
+ T cells in
splenocytes from arthropathic Tax transgenic mice
Flow cytometry using specific monoclonal antibodies against
CD19, CD3, CD4 and CD8 markers was used to determine the
phenotype of splenocytes from arthropathic Tax transgenic mice.
Figure 4. Level of autoantibodies and cytokine production in Tax transgenic mice. (A, B) Both anti-ssDNA and rheumatoid factor were
elevated significantly in arthropathic Tax transgenic mice (Arthropathy; n=7) compared with age-matched normal transgenic mice (Normal; n=9) and non-
transgenic mice (non-Tg; n=9). (C) Cytokine mRNA expression in the joints of arthropathic and healthy Tax transgenic mice. Expression of mRNAs for the
proinflammatory cytokines IL-1b, IL-6, and MIF was detected in arthropathic Tax transgenic mice but not in healthy transgenic mice. TNF-aexpression, however,
was not detected in either arthropathic or healthy transgenic mouse joint RNA. (D–F) Serum IL-6, TNF-a, and IL-17A concentrations in arthropathic (n=15) and
healthy (n=11) transgenic mice, as well as that of age-matched non-transgenic control mice (n=10). Serum IL-6 levels in arthropathic transgenic micew e r e
significantly increased compared with non-transgenic mice. * P,0.05. There was no difference in levels of serum TNF-a or IL-17A between mouse groups.
doi:10.1371/journal.pone.0018518.g004
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in Figure 6A. No group differences between non-transgenic and
arthropathic Tax transgenic mice were found in the proportion of
T cells and B cells (Figure 6A, left panel). The splenocytes of
arthropathic Tax transgenic mice showed a higher proportion of
CD8
+ T cells than CD4
+ T cells. In contrast, aged-matched non-
transgenic mice had a higher proportion of CD4
+ T cells than
CD8
+ T cells (Figure 6B). The ratio of CD4
+ T cells to CD8
+ T
cells was 2.52 in non-transgenic mice and 0.74 in arthropathic Tax
transgenic mice (Figure 6C). We then used real-time RT-PCR to
measure the expression of tax mRNA in the spleen. Splenocytes
from arthropathic Tax transgenic mice showed a 40-fold increase
in tax mRNA expression compared with age-matched healthy
transgenic mice (Figure 6D).
Decreased frequency of forkhead box protein 3 (Foxp3)
+
Treg cells in arthropathic Tax transgenic mice
The proportion of Foxp3
+ Treg cells is increased in mice with
type II collagen–induced arthritis, but Foxp3+ Treg cells do not
completely prevent the development of arthritis [17,29,30]. We
used flow cytometry to determine the proportion of Foxp3
+ Treg
cells in the spleens of arthropathic Tax transgenic mice and non-
transgenic littermates. The proportion of CD4
+CD25
+ T cells in
spleens from arthropathic Tax transgenic mice was slightly lower
than that in spleens from non-transgenic mice (Figure 7A). The
majority of CD4
+CD25
+ T cells in non-transgenic mice expressed
a high level of Foxp3 (81.261.4%), whereas only about half
(50.265.2%) of CD4
+CD25
+ T cells in arthropathic Tax
transgenic mice expressed Foxp3 (Figure 7A, B). Relative
expression of foxp3 mRNA, as determined by real-time RT-
PCR, also was lower in the spleens of arthropathic Tax transgenic
mice (Figure 7C). The proportion of CD4
+CD25
+Foxp3
+ Treg
cells among splenic CD4
+ T cells was similar among non-
transgenic and arthropathic Tax transgenic mice (Figure 7D),
probably because of the decrease in splenic CD4
+ T cells in
arthropathic Tax transgenic mice. The proportion of
CD4
+CD25
+Foxp3
+ Treg cells among splenic lymphocytes of
arthropathic Tax transgenic mice was significantly lower than that
of non-transgenic mice (Figure 7E). Patients with HAM/TSP show
a similarly lower CD4/CD8 T-cell ratio and proportion of Treg
cells [31,32].
Increased frequency of CD8
+CCR4
+ T cells in arthropathic
Tax transgenic mice
A recent report showed that a unique proinflammatory T-cell
population, IFN-c
+CCR4
+CD4
+CD25
+ T cells, termed THAM
cells, is increased in patients with HAM/TSP, with greater
proportions observed among patients with more severe disease
[33]. We used flow cytometry with a specific monoclonal antibody
against CCR4 to determine the proportion of THAM cells in the
spleens of arthropathic Tax transgenic mice and non-transgenic
littermates. CCR4-expressing CD4
+CD25
+ T cells were rare in all
tested arthropathic mice and lower than that seen in non-
transgenic mice (Figure 8, middle panel). When
CD4
+CD25
+CCR4
+ T cells from both types of mice were
cultured, no difference was found in IFN-c expression (data not
shown). In contrast, the proportion of CCR4-expressing CD8
+ T
cells was increased in arthropathic Tax transgenic mice compared
with non-transgenic mice (Figure 8, right panel).
Discussion
A transgenic mouse model of HTLV-1 by using a mouse Lck
distal promoter to express tax in mature thymocytes and peripheral
T lymphocytes developed mature T-cell leukemia/lymphoma,
similar to ATL [7]. The Tax transgenic mice also develop an
inflammatory arthropathy that is pathologically similar to human
rheumatoid arthritis and to mouse models of rheumatoid arthritis,
with synovial proliferation and rheumatoid factor expression
[22,23,34]. Transgenic mice carrying the HTLV-1 env-pX region
(pX transgenic mice) or tax with the long terminal repeat as a
promoter develop inflammatory arthritis at high incidence [8,9].
Our established Tax transgenic mice differ in several respects from
these other transgenic mice. The Tax transgenic mice developed
arthropathy after a prolonged latency period of at least 9 months,
Figure 5. Incidence and severity of arthropathy in Tax
transgenic mice injected with type II collagen. Young Tax
transgenic mice (Young Tg; 2–3 months of age; #), old Tax transgenic
mice (Old Tg; 15–16 months of age;N) and non-transgenic mice (non-
Tg; 2–3 months of age; D) were used. All mice were male (10 mice/
group) and were immunized with type II collagen in complete Freund’s
adjuvant (day 0; 1st) and boosted with type II collagen in incomplete
Freund’s adjuvant at day 21 (2nd). One of the old Tax transgenic mice
developed mild arthropathy before the first immunization. The
incidence (panel A) and severity (panel B) of arthritis was determined.
All three mouse groups were resistant to the development of type II
collagen–induced arthritis.
doi:10.1371/journal.pone.0018518.g005
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occurs as early as 4 weeks of age. At 3 months of age, 60% (BALB/
c background), 25% (C3H/He background), and 0% (C57BL/6
background) of the pX transgenic mice are afflicted with
arthropathy [35]. The genetic background of our Tax transgenic
mice was the F1 generation of a BDF1 (DBA/2 6 C57BL/6)
crossed with C57BL/6. We attempted to generate Tax transgenic
mice using the BALB/c background (backcross generation 8: N8);
however, we did not observe a high incidence of arthropathy by 24
months of age (data not shown). Cytokine gene expression of IL-
1b, IL-6, and MIF was markedly enhanced in the joints of our Tax
transgenic mice, but expression of TNF-a was not increased. Habu
et al. [36] reported that mRNA expression of IL-1b, IL-6, MIF,
and TNF-a in the joints of pX transgenic mice was increased
compared with those in non-transgenic control mice. In contrast,
Ashino et al. [37] found that serum IL-1b and IL-6 concentrations
in pX transgenic mice were significantly higher than those in non-
transgenic or non-arthritic pX transgenic mice; however, serum
TNF-a concentrations were low, with no significant differences
between groups. IL-6 is a key proinflammatory cytokine that is
abundant in the synovium and synovial tissue of patients with
rheumatoid arthritis [38]. Our results suggest that proinflamma-
tory cytokines, except for TNF-a, are important in the
development of the inflammatory arthropathy associated with
Tax expression.
Collagen is a potent inducer of arthritis in mice and rats [23].
The major histocompatibility complex loci influence the suscep-
tibility of mice to collagen-induced arthritis. Mice with the H-2
q
(DBA/1) or H-2
r (B10.RIII) haplotypes, and their congenic strains,
are highly susceptible to collagen-induced arthritis, whereas those
with the H-2
b (C57BL/6) or H-2
k (C3H) haplotypes rarely develop
arthritis [24-26]. C3H/HeN mice, which have the H-2
k
haplotype, are low responders to collagen, although pX transgenic
mice, which have a C3H/HeN genetic background, develop
collagen-induced arthritis. Kotani et al. [28] suggested that
collagen might be an arthritogenic antigen in the joints of pX
transgenic mice and that oligoclonal T-cell populations with the
same TCR Vb repertoires accumulate in collagen-induced
arthritic joints as in arthritic transgenic joints without collagen
immunization. Of note, our established Tax transgenic mice,
DBA/2 (H-2
d) 6C57BL/6 (H-2
b), did not develop arthritis after
immunization with type II collagen, in contrast to pX transgenic
mice [27,28]. Thus, different mechanisms underlie the develop-
ment of arthropathy in Tax transgenic mice and pX transgenic
mice, even though both mice express Tax.
The induction of collagen-induced arthritis in susceptible mice
involves the activation of helper T cells and B cells [39,40]. CD4
+
T cells play an important role in disease progression in the
collagen-induced arthritis model, as evidenced by the fact that
anti-CD4 treatment suppresses the onset of arthritis [10]. Th1
cells, which produce IFN-c, are considered the major player in
collagen-induced arthritis [41–44]. In fact, splenocytes from
collagen-induced arthritic mice produce a large amount of IFN-
c after antigen stimulation in vitro [12]. More recently, IL-17-
producing Th17 cells were identified. Th17 cells are implicated in
the pathogenesis of autoimmune diseases based on studies showing
that neutralization or genetic deletion of IL-17 inhibits the
development of autoimmune diseases in several mouse models,
including the collagen-induced arthritis model [14,45–47]. In
contrast, arthropathic Tax transgenic mice have a significantly
decreased proportion of splenic CD4
+ T cells. Arthropathic Tax
transgenic mice also do not have an increased level of serum IL-
17A or proportion of splenic Th17 cells (Figure S1). Furthermore,
CD8
+ T cells are increased in arthropathic Tax transgenic mice.
These results suggest that, unlike collagen-induced arthritis,
arthropathy in Tax transgenic mice does not involve IL-17A
and Th17 but may involve CD8
+ T cells.
Treg cells are potent suppressors of T-cell responses and can
play a critical role in preventing autoimmunity. It was recently
demonstrated that Foxp3 is required for Treg differentiation and
function [15]. Paradoxically, rheumatoid arthritis develops in
humans in the presence of CD4
+CD25
+ Treg cells, and Treg cells
are enriched at primary sites of autoimmune pathology [48–52].
Treg cells are also increased in animal models of rheumatoid
arthritis, such as collagen-induced arthritis. The up-regulation of
Treg cells may reflect a physiological counter-mechanism to
regulate harmful autoimmune responses [53]. In contrast to these
findings, arthropathic Tax transgenic mice have a decreased
proportion of splenic CD4
+CD25
+ T cells and a reduction in
Foxp3 expression on splenic CD4
+CD25
+ T cells; these results are
similar to those observed in HAM/TSP patients [32].
Yamano et al. [33] reported that THAM cells are increased in
HTLV-1-infected T cells in HAM/TSP patients, whereas THAM
cells are rare in ATL patients and in healthy individuals.
Arthropathic Tax transgenic mice did not have detectable levels
of THAM cells; however, they did have increased CD8
+ T cells
expressing the chemokine receptor CCR4 (CD8
+CCR4
+). The
proportion of CD8
+CCR4
+ T cells is increased in the peripheral
blood of patients with psoriasis and palmoplantar pustulosis
[54,55], and CD8
+CCR4
+ T cells effectively produce IL-4, IFN-c,
IL-2, and TNF-a [56]. These reports suggest that CD8
+CCR4
+ T
cells may be involved in the pathogenesis of these diseases. Future
studies should examine levels of both CD4
+CCR4
+ T cells and
CD8
+CCR4
+ T cells in HAM/TSP patients.
The bilateral tarsal joint, which supports the whole weight of a
mouse, is destroyed in arthropathic Tax transgenic mice. We
speculate that blood flow in this joint may be lower than in other
joints. Tax expression may reduce the expression of Foxp3, which
regulates Treg development and function [15]. Furthermore, age
may reduce the suppressor function of Treg cells. Autoimmune T
cells, such as CD8
+CCR4
+ T cells, may not be suppressed by Treg
cells and thus may enter the circulation. Autoimmune T cells may
then infiltrate the tarsal joint where the blood flow is lower.
In conclusion, this study provides new and important informa-
tion on the pathogenic mechanism of arthropathy in Tax
transgenic mice, which differs from the pathogenic mechanism
of rheumatoid arthritis in other mouse models. Tax transgenic
mice develop rheumatoid-like arthritis with proliferating synovial
cells in the joints; however, T-cell subsets in these mice resemble
those of HAM/TSP rather than rheumatoid arthritis. These
results raise the possibility that Tax transgenic mice might be used
to study the pathogenic mechanisms of, or therapeutic agents for,
Figure 6. Phenotype of T cells in arthropathic mice. (A) A representative flow cytometric analysis of splenocytes stained with monoclonal
antibodies to examine the expression of CD19 versus CD3, CD3 versus CD4, and CD3 versus CD8 in arthropathic Tax transgenic mice (Arthropathy;
lower panel) and age-matched non-transgenic mice (non-Tg; upper panel). (B) Arthropathic Tax transgenic mice showed a lower proportion of CD4
+ T
cells and a higher proportion of CD8+ T cells than age-matched non-transgenic mice (n=8 per group). * P,0.05. (C) The ratio of CD4
+ T cells to CD8
+
T cells (CD4
+/CD8
+) changed from 2.52 in the non-transgenic mice to 0.74 in arthropathic Tax transgenic mice (n=8 per group) ** P,0.01. (D) The
expression of tax mRNA in the spleen of arthropathic Tax transgenic mice was higher than that in healthy transgenic mice (n=5 per group) * P,0.05.
doi:10.1371/journal.pone.0018518.g006
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developed.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guidelines for Proper Conduct of Animal
Experiments, Science Council of Japan (http://www.scj.go.jp/en/
animal/index.html). All procedures involving animals and their
care were approved by the Animal Care Committee of
Kumamoto University in accordance with Regulations for Animal
Experiments in Kumamoto University (approval ID: B22-122).
Generation of Tax transgenic mice
We developed a transgenic mouse model of HTLV-I using a
mouse Lck distal promoter to express tax in mature thymocytes and
peripheral T lymphocytes. A 1.3-kb gene fragment encompassing
tax was amplified by nested PCR using Ex Taq (Takara Bio, Shiga,
Japan) from the tax expression vector, pH2R40M [57]. pH2R40M
was a gift from Drs. T. Nakashima and M. Nakazawa, St.
Marianna University School of Medicine (Kawasaki, Janan).
Primers used for the first PCR were MTAX11 and MTAX01
[58]. After the first PCR reaction with 30 cycles, an aliquot of the
amplified product was subjected to an additional 30 cycles in a
second PCR using internal primers, TAX1 (59-CTTAA-
TAGCCGCCAGTGGAA-39) and BTAX0 (59-CGCGGATCC-
CGGAGGTCTGAGCTTATGAT-39); the BamHI site is under-
lined. Each PCR cycle consisted of denaturation at 94uC for
1 min, annealing at 55uC for 1 min, extension at 72uC for
1.5 min, and extension in the final cycle at 72uC for 10 min. The
amplified fragments were digested with BamHI, separated by
agarose gel electrophoreses, purified, and subcloned into the
BamHI site of the pUC19 vector containing the Lck distal
promoter, pw120 [59]. pw120 was a gift from Drs. T. Nakayama
and C. Shimizu, Chiba University School of Medicine (Chiba,
Figure 7. Significantly decreased levels of CD4
+CD25
+ Treg cells in arthropathic Tax transgenic mice. (A) Representative flow cytometric
analysis of Foxp3 staining in gated CD4
+CD25
+ cells in arthropathic Tax transgenic mice (Arthropathy; lower panel) and age-matched non-transgenic
mice (non-Tg; upper panel). (B) The majority of CD4
+CD25
+ T cells in non-transgenic mice expressed a high level of Foxp3 (81.261.4%), whereas half
of CD4
+CD25
+ T cells in arthropathic Tax transgenic mice did not express Foxp3 (50.265.2%) (n=6 per group), *** P,0.001. (C) The relative
expression of splenic foxp3 mRNA was decreased in arthropathic Tax transgenic mice compared with non-transgenic mice (n=6 per group),
*** P,0.001). (D) The percentage of CD4
+CD25
+Foxp3
+ Treg cells in CD4
+ T cells did not differ between arthropathic Tax transgenic mice and non-
transgenic mice (n=6 per group). (E) Arthropathic Tax transgenic mice showed a significant decrease in the percentage of CD4
+CD25
+Foxp3
+ Treg
cells in splenic lymphocytes compared with non-transgenic mice (n=6 per group), ** P,0.01.
doi:10.1371/journal.pone.0018518.g007
Figure 8. Increased frequency of CD8
+CCR4
+ T cells in arthropathic Tax transgenic mice. A representative flow cytometric analysis of
CCR4-expressing T cells in gated CD4
+CD25
+ or CD8+ T cells in arthropathic Tax transgenic mice (Arthropathy; lower panel) and age-matched non-
transgenic mice (non-Tg; upper panel). The proportion of CCR4-expressing CD4
+CD25
+ cells in arthropathic Tax transgenic mice (Arthropathy, lower
middle panel) was lower than that of age-matched non-transgenic mice (non-Tg; upper middle panel), whereas the percentage of CD8
+CCR4
+ T cells
was increased in arthropathic Tax transgenic mice compared to non-transgenic mice (right panels).
doi:10.1371/journal.pone.0018518.g008
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was sequenced and found to match completely with the reported
tax sequence [58,60]. After being checked for proper orientation
using PCR, the plasmid was digested with NotI, and linear insert
DNA was prepared (Figure S2A) and microinjected into the
pronuclei of BDF1 (C57BL/6 6 DBA/2) mouse zygotes.
Offspring were obtained after implantation. We biopsied 1-cm
portions of tail from 4-week-old mice under ether anesthesia. Tail
DNA was isolated using DNA extraction kits (Qiagen, Valencia,
CA). To verify integration of tax in the host chromosome, tail
DNA was digested with BamHI and EcoRI and analyzed by
Southern blotting using the SK45 probe[61]. Labeling of the
probe was carried out by PCR with digoxigenin 11-deoxy UTP
(DIG-11-dUTP: Roche Diagnostics, Mannheim, Germany).
Specific hybridization was visualized by an enzymatic color
reaction on the filter (Figure S2B). A 1.3-kb band of the expected
length for tax was detected in BamHI-digested genomic DNA from
the transgenic mice (Figure S2B, left). A 7.5-kb band of the whole
transgene was detected in EcoRI-digested genomic DNA. EcoRI
digests one site in the transgene; thus, the transgene in the
transgenic mice was integrated in a head-to-tail configuration. The
tax copy number was examined by Southern blotting of BamHI-
digested genomic DNA from transgenic mice in parallel with a
serially diluted plasmid-containing tax cDNA. The copy number
was estimated to be approximately 20 copies per genome (Figure
S2B, right). The expression of tax mRNA in various organs of
transgenic mice was examined by quantitative real-time RT-PCR.
The thymus and spleen strongly expressed tax mRNA (Figure
S2C).
Animal maintenance
Tax transgenic mice (background strain BDF1) were crossed
with C57BL/6 mice. The F1 mice were used for the present
studies. Integration of tax into the host chromosome was verified.
Genomic DNA prepared from the tail of each mouse using DNA
extraction kits (Qiagen). Routine identification of transgenic mice
was done by PCR [61,62]. For Southern blot analysis, genomic
DNA (10 mg) was digested with BamHI and EcoRI, electrophoresis
was conducted using a 0.9% agarose gel, followed by Southern
blotting with a probe containing the SK45 sequence [61]. The
mice were maintained under specific pathogen-free conditions in
laminar-flow benches at 2262 uC with a 12 h light/dark cycle.
Food (CE-2; CLEA, Tokyo, Japan) and water were supplied ad
libitum. The animals were euthanized by an overdose of sodium
pentobarbital anesthesia, and all efforts were made to minimize
suffering.
Real-time PCR
Total RNA from lesion sites of arthropathic Tax transgenic
mice and from spleens of age-matched healthy transgenic mice
was isolated using RNA extraction kits (Qiagen). Approximately
0.5 mg of total RNA was reverse transcribed with a cDNA Reverse
Transcription kit (Applied Biosystems, Foster City, CA). To
measure HTLV-1 tax expression, real-time PCR was performed as
described [62]. Expression of tax mRNA in lesions of each disease
was calculated and compared to that in spleens of healthy aged-
match Tax transgenic mice.
To measure foxp3 expression in splenocytes of arthropathic Tax
transgenic mice, real-time PCR was performed using a SYBR
Green PCR Master Mix (Applied Biosystems) according to the
manufacturer’s instructions on an ABI-Prism 7700 Sequence
Detector (Applied Biosystems). Primers for foxp3 were as follows:
foxp3 sense, 59-TACACCCAGGAAAGACAGCAACCT-39, and
antisense, 59-TCTGCTTGGCAGTGCTTGAGAA-39 [63]. Am-
plification of mouse b-actin (sense, 59-TGTCCCTGTA-
TGCCTCTGGT-39, and antisense, 59-GATGTCACGCAC-
GATTTCC-39) was used to normalize values of target gene
expression.
Clinical evaluation
Arthropathy was evaluated until 24 months of age. Joint
swelling was monitored in blinded cages by two independent
animal technicians. Joints of each paw were examined weekly, and
scoring was performed as follows: 0 = normal; 1 = swelling and
redness of the joints; 2 = obvious swelling; 3 = joint rigidity.
X-ray examination
X-ray examination of the joints of arthropathic mice was
conducted using a mFX-1000 digital microradiography system
(Fujifilm, Tokyo, Japan) set at 25 kV and 80 mA with a 6-sec
exposure with an imaging plate. The film was scanned and
analyzed using a BAS-2000 bioimage analyzer (Fujifilm).
Administration of type II collagen
Chicken type II collagen (Chondrex, Redmond, WA) (2 mg/ml)
was emulsified 1:1 with Freund’s complete adjuvant (Difco
Laboratories, Detroit, MI). Collagen (100 mg) was injected
intradermally at the base of the tail of male mice at 2–3 months
of age (young) or 15–16 months of age (old). Three weeks after the
first immunization, 100 mg of chicken type II collagen emulsified
1:1 with Freund’s incomplete adjuvant was similarly injected.
Tissue collection and assays
The mice were euthanized with an overdose of sodium
pentobarbital, blood samples were obtained at the time of death
by direct cardiac puncture. Serum was frozen at 280u C for
various assays to be performed at a later date. Spleens were
collected, and single-cell suspensions were made for use in flow
cytometry. Joints were harvested for tissue histology and analysis of
cytokine mRNA. Joints were fixed in 10% neutral-buffered
formalin immediately after removal, embedded in paraffin, cut
into 4- mm sections, and stained with hematoxylin and eosin using
standard protocols.
Semi-quantitative RT-PCR
Cytokine mRNA expression was measured in the swollen joints
of arthropathic mice and the normal joints of healthy mice using
semi-quantitative RT-PCR. Briefly, the joints were removed
quickly from the skin, frozen in liquid nitrogen, and stored at
280uC. Frozen joints (without the skin) were homogenized with a
Polytron homogenizer (PT1300D; Kinematica, Inc., Bohemia,
NY). Total RNA was extracted from the joints using an RNA
extraction kit (Qiagen) and treated with DNase. Total RNA was
then reverse transcribed with reverse transcriptase, and the
resultant cDNAs were amplified using primers specific for IL-1b,
TNF-a, IL-6, and MIF and a mouse b-actin primer pair as an
internal control [64]. Primers for IL-1b, TNF-a, IL-6, MIF, and b-
actin were as follows: IL-1b sense, 59-CCCAAGCAATACC-
CAAAGAA-39, and antisense, 59-CATCAGAGGCAAGGAG-
GAAA-39; TNF-a sense, 59-GCCTCTTCTCATTCCTGCTT-
39, and antisense, 59-CACTTGGTGGTTTGCTACGA-39; IL-6
sense, 59-TTCCATCCAGTTGCCTTCTT-39, and antisense, 59-
ATTTCCACGATTTCCCAGAG-39; MIF sense, 59-TGACT-
TTTAGCGGCACGAAC -39, and antisense, 59-GACTCAAGC-
GAAGGTGGAAC-39; and b-actin sense, 59-TGTCCCTGTAT-
GCCTCTGGT-39, and antisense, 59-GATGTCACGCACGA-
TTTCC-39. The PCR was carried out by heating the mixture at
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30 sec, annealing at 60uC for 30 sec, extension at 72uC for 1 min,
and extension in the final cycle at 72uC for 10 min.
Measurement of cytokine concentrations
Serum concentrations of IL-1b, IL-6, IL-17A, TNF-a, and IFN-
c were determined by qualitative analysis using an ELISA kit for
the detection of mouse inflammatory cytokines (SABiosciences,
Frederick, MD) and by quantitative analysis using the single
cytokine detection kit (R&D Systems, Minneapolis, MN).
Measurement of NF-kB activity
Nuclear fractions were prepared from joint tissue using a
nuclear extraction kit according to the manufacturer’s protocol
(Active Motif, Carlsbad, CA). DNA-binding activity of NF-kB p65
was then measured using microplate-based ELISA according to
the manufacturer’s protocol (Active Motif).
Measurement of Ca
2+ levels
Serum Ca
2+ levels were measured by a QuantiChrom calcium
assay kit (BioAssay Systems, Hayward, CA) according to the
manufacturer’s protocol.
Quantification of autoantibodies
Serum levels of anti-ssDNA IgG and rheumatoid factor were
measured using ELISA kits for the detection of mouse anti-ssDNA
and IgG rheumatoid factor (Shibayagi, Gunma, Japan).
Flow cytometry
Cell populations from spleens were examined using flow
cytometry. Single-cell suspensions were prepared from the
enlarged spleens of transgenic mice and from the spleens of non-
transgenic littermates, which were used as controls. The samples
were treated with ammonium chloride to lyse red blood cells. For
two-color staining, cells were stained with fluorescein isothiocya-
nate (FITC)2labeled anti-mouse CD3 (145-2C11) and phycoer-
ythrin (PE)-labeled anti-mouse CD19 (MB19-1) from eBioscience
(San Diego, CA). For three-color staining, cells were stained with
FITC-labeled anti-mouse CD4 (RM4-5), PE-labeled anti-mouse
CD8 (53-6.7), and allophycocyanin (APC)-labeled anti-mouse
CD3 (145-2C11) from eBioscience. To determine the intracellular
expression of the Treg cell–specific transcription factor Foxp3 in
CD4
+CD25
+ cells, mouse splenocytes were first surface-stained
with PE-labeled anti-mouse CD4 (RM4-5) and APC-labeled anti-
mouse CD25 (PC61.5) from eBioscience. The cells were then fixed
using a staining buffer set (BioLegend; San Diego, CA) and
intracellularly stained with Alexa Fluor 4882labeled anti-mouse
Foxp3 (BioLegend) or Alexa Fluor 4882labeled anti-mouse
IgG1,k (BioLegend). For four-color staining, cells were stained
with FITC-labeled anti-mouse CD8 (53-6.7; eBioscience), PE-
labeled anti-mouse CCR4 (2G12; BioLegend), peridinin chloro-
phyll protein (PerCP)2labeled anti-mouse CD25 (PC61; BioLe-
gend), and APC2labeled anti-mouse CD4 (RM4-5; eBioscience).
Intracellular cytokines were labeled after activation of lymphocytes
by culture for 5 h with phorbol 12-myristate 13-acetate and
ionomycin (50 ng/ml and 1 mg/ml, respectively). Splenocytes
were then stained using a mouse Th1/Th17 phenotyping kit (BD
Biosciences; San Jose, CA). Flow cytometry was conducted using a
FACSCalibur (Becton Dickinson; Franklin Lakes, NJ) with FlowJo
software (Tree Star; Ashland, OR). Forward and side scatter
profiles were used to gate on the lymphocyte population.
Statistical analysis
All data are presented as the mean 6 SEM. Unless otherwise
indicated, statistical testing was performed using a two-tailed,
unpaired, Student’s t-test for the analysis of differences in mean
values between groups. We assessed statistical significance for the
gender difference with respect to the cumulative incidence of T-
cell leukemia/lymphoma or arthropathy in mice with Fisher’s
exact test. P values,0.05 were considered significant.
Supporting Information
Figure S1 Phenotype of Th1/Th17 cells in arthropathic
mice. The staining of interferon-c (IFN-c) and IL-17A on resting
splenocytes (left panel) and splenocytes stimulated with phorbol
12-myristate 13-acetate/ionomycin (right panel). A small number
of IL-17-producing cells was detected in age-matched non-
transgenic mice (A), whereas very few IL-17-producing splenocytes
were detected in arthropathic Tax transgenic mice (B) (0.5% and
,0.1%, respectively). The dot plots are derived from a combined
forward- and side-scatter and CD4
+ gate.
(TIF)
Figure S2 Construction of the tax transgene and tax
mRNA expression in transgenic mice. (A) Schematic
diagram of constructs used for peripheral T cell–specific
expression of tax. HTLV-1 tax was inserted into the BamHI site
of the pw120 vector under the control of the mouse Lck distal
promoter. The 7.5-kb fragment digested by the plasmid NotI was
used for microinjection. (B) Southern blot analysis of the transgene
in Tax transgenic mice (Tg). The position of the tax hybridization
probe (SK45) is indicated in panel A. The expected bands of
1.3 kb and 7.5 kb were detected in the genomic DNA from Tax
transgenic mice digested with BamHI or EcoRI (left panel). These
bands were absent in non-transgenic mice (N). The tax copy
number was examined by Southern blotting of BamHI-digested
genomic DNA from Tax transgenic mice in parallel with serially
diluted plasmid-containing tax cDNA (right panel). (C) Relative
expression of tax mRNA in various organs of Tax transgenic mice
was examined using quantitative real-time RT-PCR. b-actin was
used to normalize the values of target mRNA expression.
(TIF)
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